Sat Kartar Life Ltd

Sat Kartar Life Earnings Call Transcript: Key Takeaways

Sat Kartar Life is pivoting from pure Ayurveda products to an integrated healthcare model, showing strong revenue growth but scaling back prior top-line guidance to prioritize margins.

Call

Guides 32% growth

Sat Kartar Life Investor Presentation: Key Takeaways

H1 FY27 deck discloses no revenue, PAT or EBITDA figures. Balance sheet is debt-free with ₹18.7 Cr net cash. Growth is hospital-led: 30-bed Delhi unit at breakeven, 300 beds targeted by FY27-end.

Sat Kartar Life Earnings Call: Key Takeaways

Sat Kartar Life reported 23% revenue growth crossing ₹200cr in FY26. Transitioning from product-focused to an integrated Ayurvedic healthcare ecosystem including hospitals.

Sat Kartar Life Earnings Call: Key Takeaways

Sat Kartar Life transitioned from a product-focused entity to a healthcare ecosystem, delivering record growth in FY26. Management is aggressively targeting 150% revenue growth by FY28 through massive hospital bed expansion and US market entry.